Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 33, 2019 - Issue 15
175
Views
4
CrossRef citations to date
0
Altmetric
Short Communication

Phytosterols in supplements containing Serenoa repens: an example of variability of active principles in commercial plant based products

, , , , &
Pages 2257-2261 | Received 20 Feb 2018, Accepted 13 Jun 2018, Published online: 08 Oct 2018

References

  • Abdel Bar FM. 2015. New chalcanonol glycoside from the seeds of saw palmetto: antiproliferative and antioxidant effects. Nat Prod Res. 29:926–932.
  • Allkanjari O, Vitalone A. 2015. What do we know about phytotherapy of benign prostatic hyperplasia? Life Sci. 126:42–56.
  • De Monte C, Carradori S, Granese A, Di Pierro GB, Leonardo C, De Nunzio C. 2014. Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms. BMC Urol. 14:63–73.
  • European Medicine Agency (EMA), Commitee on Herbal Medicinal Products. 2015 Nov 24. European Union Herbal Monograph on Serenoa repens (W. Bartram) Small, fructus. EMA/HMPC/280079/2013. Available from: http://www.e-lactancia.org/media/papers/Sabal-EMA2013.pdf [last accessed 13 Jun 2018]
  • EU Pharmacopeia. 2017. 9th Ed (On-line Ed. 9.2). Saw Palmetto Extract. 01/2014:2579.
  • Habib FK, Wyllie MG. 2004. Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract. Prostate Cancer Prostatic Dis. 7:195–200.
  • Lowe FC. 2009. The Role of Serenoa repens in the Clinical Management of Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia. Eur Urol Suppl. 8:894–897.
  • MacDonald R, Tacklind JW, Rutks I, Wilt TJ. 2012. Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review. BJU Int. 109: 1756–1761.
  • Novara G, Giannarini G, Alcaraz A, Cózar-Olmo JM, Descazeaud A, Montorsi F, Ficarra V. 2016. Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol Focus. 2: 553–561.
  • Ooi SL, Pack SC. 2017. Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and Its Clinical Implications in Naturopathic Medicine. J Altern Compl Med. 23:599–606.
  • Penugonda K, Lindshield BL. 2013. Fatty Acid and Phytosterol Content of Commercial Saw Palmetto Supplements. Nutrients. 5:3617–3633.
  • Sorenson WR, Sullivan D. 2007. Determination of campesterol, stigmasterol, and beta-sitosterol in saw palmetto raw materials and dietary supplements by gas chromatography: collaborative study. J AOAC Int. 90:670–678.
  • Suter A, Saller R, Riedi E, Heinrich M. 2013. Improving BPH symptoms and sexual dysfunctions with a saw palmetto preparation? Results from a pilot trial. Phytother Res. 27:218–226.
  • Tacklind J, MacDonald R, Rutks I, Stanke JU, Wilt TJ. 2012. Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2012;CD001423. DOI: 10.1002/14651858.CD001423.pub3.
  • The United States Pharmacopeial Convention. 2013. Saw palmetto extract. Revision Bulletin. Available from: http://www.uspnf.com/official-text/revision-bulletins/saw-palmetto-extract.
  • World Health Organization (WHO). 2004. Fructus serenoae repentis. In: WHO Monographs on Selected Medicinal Plants. Vol. 2. Geneva: WHO; p. 285–299. Available from: http://apps.who.int/iris/bitstream/handle/10665/42052/9241545372.pdf?sequence=2&ua=1 [Last accessed 20 Aug 2018].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.